Clinical trial
Efficacy and Safety of Different Dosage Regimens of the Combination Methocarbamol/Paracetamol in Acute Low Back Pain (LBP): MioPain Study
NCT05204667 is registered in ClinicalTrials.gov with Aziende Chimiche Riunite Angelini Francesco S.p.A as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Different Dosage Regimens of the Combination Methocarbamol/Paracetamol in Acute Low Back Pain (LBP): MioPain Study
- Lead sponsor
- Aziende Chimiche Riunite Angelini Francesco S.p.A
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- October 7, 2021
- Completion date
- February 28, 2024
- Enrollment
- 172 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.